Solomayer E F, Diel I J, Meyberg G, Sinn H P, Emig R, Wallwiener D, Bastert G
Universitäts-Frauenklinik Heidelberg.
Zentralbl Gynakol. 1998;120(7):337-40.
We report on a patient with metastatic breast cancer confined to visceral (lung and pleura) site. A high-dose chemotherapy with peripheral progenitor blood cell transplantation was indicated. In contrast to other 24 patients two induction cycle chemotherapies (intensive dosis of Epirubicin/Ifosfamid/GCSF) didn't show any remission of metastases. Therefore a high dose chemotherapy with peripheral progenitor blood cell transplantation was not indicated any more. This patient had lung and pleura metastases and showed a complete remission after the following conventional chemotherapy (Carboplatin/Toxol) persisting more than 7 months. Non-responder after induction therapies have a poor prognosis but salvage therapy may be successful anyway. Mammary neoplasms can be sensible on special chemotherapy drugs only.
我们报告了一名转移性乳腺癌局限于内脏(肺和胸膜)部位的患者。已表明需进行高剂量化疗并联合外周祖细胞移植。与其他24名患者不同,两个诱导周期的化疗(表柔比星/异环磷酰胺/粒细胞集落刺激因子的强化剂量)并未使转移灶出现任何缓解。因此,不再建议进行高剂量化疗并联合外周祖细胞移植。该患者有肺和胸膜转移,在接受后续常规化疗(卡铂/紫杉醇)后出现完全缓解,缓解持续超过7个月。诱导治疗后无反应者预后较差,但挽救治疗仍可能成功。乳腺肿瘤可能仅对特定的化疗药物敏感。